Myelodysplastic syndrome (MDS)

This study is looking at a type of treatment called intestinal microbiota transplant. It’s a way of encouraging more variety in gut bacteria.

This trial looked at an immunotherapy drug called magrolimab alone or with azacitidine for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS).

This study is assessing the value of prehabilitation for people with acute myeloid leukaemia and myelodysplastic syndrome.

This study is comparing 2 treatments for myelodysplastic syndromes to increase the number of blood cells.

This trial is comparing standard treatment with 2 newer combinations of treatment to prevent GvHD.

This study is looking at a new drug called INCB057643 to treat cancers that affect how well the bone marrow works.

This trial is for people with blood cancer that has come back or is getting worse despite treatment.

This trial is looking at new combinations of chemotherapy before a stem cell transplant to improve treatment for people with AML and MDS.

This trial is looking at a drug called azacitidine after a stem cell transplant for people who have acute myeloid leukaemia or high risk myelodysplasia.

This trial is looking at rigosertib for people who have already had treatment for their myelodysplastic syndrome (MDS).